Canadian consensus: oligoprogressive, pseudoprogressive, and oligometastatic non-small-cell lung cancer

BACKGROUND: Little evidence has been generated for how best to manage patients with non-small-cell lung cancer (nsclc) presenting with rarer clinical scenarios, including oligometastases, oligoprogression, and pseudoprogression. In each of those scenarios, oncologists have to consider how best to ba...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Curr Oncol
Päätekijät: Laurie, S.A., Banerji, S., Blais, N., Brule, S., Cheema, P.K., Cheung, P., Daaboul, N., Hao, D., Hirsh, V., Juergens, R., Laskin, J., Leighl, N., MacRae, R., Nicholas, G., Roberge, D., Rothenstein, J., Stewart, D.J., Tsao, M.S.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Multimed Inc. 2019
Aiheet:
Practice Guideline
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6380642/
https://ncbi.nlm.nih.gov/pubmed/30853813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.26.4116
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia